At a glance
ClinicalIndex Comparison RecordN/ACompleted· 78 enrolled
Drug / intervention
IV racemic methadone HCl +1 moredrug
Likely dose
IV racemic methadone HCl 6 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Role of CYP2B6 Polymorphisms in Methadone Metabolism and Clearance
In Brief
A clinical study evaluating IV racemic methadone HCl and Oral racemic methadone HCl for Healthy Volunteers. Completed, enrolled 78 participants across 1 site.
Detailed Summary
This research study will determine if genetic variation in CYP2B6 affects how the body metabolizes methadone.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 2012
Enrollment StartNov 2012
Primary CompletionMar 2015
Study CompletionJun 2015
TodayJul 2026
First PostedJul 24, 2012
Enrollment StartNov 1, 2012
Primary CompletionMar 1, 2015
Study CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 13.9 years ago
Interventions
IV racemic methadone HCldrug
IV racemic Methadone HC1 6 mg
Oral racemic methadone HCldrug
oral d5-methadone HCl 11 mg